Terumo Corporation

Research Terumo Corporation (TUO0) on Bullrun: valuation model: 1.5% overvalued, market cap EUR 17.11B, P/E 23.2, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTUO0
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyEUR
• Valuation signal1.5% overvalued
• Market capEUR 17.11B
• P/E23.2
• Dividend yield1.4%
• Financial periodFY2025
• RevenueEUR 1.04T
• Revenue growth12.4%
• Net incomeEUR 116.98B
• Free cash flowEUR 128.44B
• Gross margin54.1%

Valuation Snapshot

Bullrun's latest valuation model marks Terumo Corporation as 1.5% overvalued; latest market cap is EUR 17.11B; P/E is 23.2; dividend yield is 1.4%.

About Terumo Corporation

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.

Frequently asked questions

Is Terumo Corporation overvalued or undervalued?

Bullrun's valuation model currently marks Terumo Corporation as 1.5% overvalued.

What is Terumo Corporation's market cap?

Terumo Corporation's market capitalization is EUR 17.11B.

What is Terumo Corporation's P/E ratio?

Terumo Corporation's price-to-earnings (P/E) ratio is 23.2.

Does Terumo Corporation pay a dividend?

Terumo Corporation has a dividend yield of 1.4%.

What does Terumo Corporation do?

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.